image
Vigil Neuroscience, Inc. VIGL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.19
0.315 %
$ 130 M
Market Cap
-1.54
P/E
BALANCE SHEET
141 M ASSETS
-29.71%
Growth Rates
1Year -29.71%
3Years 77.25%
5Years 0.00%
7Years 0.00%
10Years 0.00%
24.6 M LIABILITIES
117.52%
Growth Rates
1Year 117.52%
3Years -22.85%
5Years 0.00%
7Years 0.00%
10Years 0.00%
116 M EQUITY
-38.52%
Growth Rates
1Year -38.52%
3Years 82.82%
5Years 0.00%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Vigil Neuroscience, Inc.
image
Current Assets 122 M
Cash & Short-Term Investments 118 M
Receivables 1.48 M
Other Current Assets 2.48 M
Non-Current Assets 19 M
Long-Term Investments 0
PP&E 17.9 M
Other Non-Current Assets 1.01 M
Current Liabilities 11.7 M
Accounts Payable 1.95 M
Short-Term Debt 1.81 M
Other Current Liabilities 7.9 M
Non-Current Liabilities 12.9 M
Long-Term Debt 12.9 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 52.0 186.6 91.4 24.2
Short Term Investments 65.9 0 0 0
Receivables 1.5 0 0 0
Inventory 0 10.6 0 0
Other Current Assets 2.5 11.2 6.1 1.1
Total Current Assets 121.9 197.8 97.5 25.3
PP&E 17.9 1.4 1.3 0
Intangible Assets 0 0 0 0
Goodwill 0 0 0 0
Long Term Investments 0 0.9 0 0
Other Long Term Assets 1.0 0.3 3.7 0
Other Assets 0 0 0 0
Total Assets 140.9 200.4 102.4 25.3
LIABILITIES
Accounts Payable 1.9 1.9 4.0 1.1
Short Term Debt 1.8 0.4 1.7 0
Other Current Liabilities 7.9 9.0 4.2 0.9
Total Current Liabilities 11.7 11.3 9.9 2.0
Long Term Debt 12.9 0 64 K 303
Deferred Tax Income 0 0 0 0
Other Liabilities 0 0 161.9 51.6
Total Liabilities 24.6 11.3 171.9 53.6
EQUITY
Common Stock 4 K 4 K 0 0
Retained Earnings (222.8) (140.1) (71.8) (28.5)
Other Accumulative Comprehensive Income/Loss 5 K 0 0 0
Total Equity 116.3 189.1 (69.4) (28.3)
Total Liabilities and Equity 140.9 200.4 102.4 25.3
SHARES OUTSTANDING
Common Shares Outstanding 38.7 31.7 1.5 28.3